Metrics Used for the Evaluation of Chatbots Providing Cancer Genetic Risk Assessment and Education: Systematic Review.

Jennifer L Scalia¹, Jessica L Laprise², Jason R Thrift¹, Christopher L Farrell¹, Sara M Sarasua¹

¹School of Nursing, Clemson University, 436 Edwards Hall, Clemson, SC, 29634, United States, 1 401-230-3883.

²Ambry Genetics, Aliso Viejo, CA, United States.

Abstract

BACKGROUND: Chatbots have recently emerged as an alternative approach for delivering cancer risk assessment and genetic counseling. Understanding the metrics used to describe the user-chatbot experience highlights the strengths and weaknesses of chatbot-assisted health care applications, ensuring safe and reliable medical care. While research supports chatbots in cancer genetic risk assessment and…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.